S1 Biopharma

Today, we’ve announced that the European Patent Office has granted a patent for our proprietary dual-mechanistic investigational therapy for hypoactive sexual desire disorder. For more information, see our press release. http://ow.ly/Jlys30n3XG2

We're glad to see the U.S. Food and Drug Administration focusing more attention on female sexual health. This new draft guidance for industry shares some important perspectives on the development of drugs for the treatment of low sexual interest, desire, and/or arousal in women. http://www.fda.gov//GuidanceCompl/Guidances/UCM526362.pdf

Really glad to see Fox News took the time to talk with Dr. Anita Clayton, a member of our scientific advisory board since '12, for this article on sexual health and low libido http://www.foxnews.com//9-reasons-dont-want-to-have-sex-an

"In some ways, sexual desire is a barometer of your overall health. If someone comes in with a low libido, it can often be an indication that something else is going on emotionally or physically. - Ian Kerner, PhD, a psychotherapist and sex therapist in New York City http://www.everydayhealth.com//things-women-need-happy-he/

Check out page 8 of the June issue of Pharmafocus for an interview with our CEO Nick Sitchon... nice overview of our HSDD research http://edition.pagesuite-professional.co.uk/launch.aspx